Tokyo Univ. continuing probes into neutrino research accident

Tokyo Univ. continuing probes into neutrino research accident

TOKYO, Japan - Motohiko Yoshimura (R), director at the University of Tokyo's Institute for Cosmic Ray Research (ICRR),speaks at a news conference at the university Nov. 13, 2001 on an accident the previous day at its cosmic ray research body in Gifu Prefecture where more than half of the 11,000 photomultiplier tubes (PMTs) attached to a large neutrino detector were found broken.

  • Product Code
  • ILEA000010683
  • Registered date
  • 2001/11/13 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1215 × 1777 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 567.38(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    KM Biologics begins development of vaccine for novel coronavirus

    KM Biologics begins development of vaccine for novel coronavirus

    KM Biologics (Kita Ward, Kumamoto City) has started to develop a vaccine for a new coronavirus infection. At a press conference held on April 25, President Nagasato said, "Our strength lies in the fact that we have skilled technicians and facilities from our days at the Research Institute for Chemotherapy and Serotherapy (KAKETSUKEN). As a member of the Meiji Group, we will do our utmost to expand this business. The new drug will be developed jointly with the National Institute of Infectious Diseases, the Institute of Medical Science of the University of Tokyo, and the National Institute of Biomedical Innovation, Health and Nutrition. The company will consider using its Kikuchi Research Center in Kikuchi City, Kumamoto Prefecture, and its Koshi Plant in Koshi City, Kumamoto Prefecture, which are capable of producing vaccines for 57 million new influenza cases. (Photo taken on May 25, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
      Japan Education Association estimates the cost of switching to September enrollment

      Japan Education Association estimates the cost of switching to September enrollment

      The Japan Society for Educational Research (JSSER) (Chiyoda Ward, Tokyo; Teruyuki Hirota, President; Professor, Nihon University, College of Letters, Science and Technology) has estimated the cost of the government's plan to switch to September enrollment, which totals more than 6 trillion yen. The government, local governments and households will have to pay more than 1.816 trillion yen to cover the cost of the change, which will lead to the improvement of not only emergency response to the new coronavirus infection but also long-term educational issues.Photo: Teruyuki Hirota (right), president, and Akio Inui, chairman of the special committee to study the issue of September enrollment and the first day of school, at a press conference on May 22, 2020, at the Ministry of Education, Culture, Sports, Science and Technology in Kasumigaseki, Chiyoda-ku, Tokyo.
        Press conference on the identification of existing drugs in Japan

        Press conference on the identification of existing drugs in Japan

        Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
          Press conference on the identification of existing drugs in Japan

          Press conference on the identification of existing drugs in Japan

          Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
            Press conference on the identification of existing drugs in Japan

            Press conference on the identification of existing drugs in Japan

            (From right) Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science of the University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science of the University of Tokyo, wearing masks at the press conference. The University of Tokyo's Yasuda Auditorium, Bunkyo Ward, Tokyo, March 18, 2020.
              Press conference on the identification of existing drugs in Japan

              Press conference on the identification of existing drugs in Japan

              Scene of the press conference. (From right) Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science, University of Tokyo. The University of Tokyo Yasuda Auditorium, Bunkyo-ku, Tokyo, March 18, 2020.
                Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

                Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

                Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Press conference on the identification of existing drugs in Japan

                  Press conference on the identification of existing drugs in Japan

                  Photo shows Kohei Miyazono, Executive Vice President (Research) of the University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                    Press conference on the identification of existing drugs in Japan

                    Press conference on the identification of existing drugs in Japan

                    Scene of the press conference. (From right) Kohei Miyazono, Executive Vice President for Research at the University of Tokyo, Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science at the University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science at the University of Tokyo. (From right to left: Dr. Kohei Miyazono, Vice President for Research, The University of Tokyo; Dr. Yuji Yamanashi, Director, Institute of Medical Science, The University of Tokyo; and Dr. Junichiro Inoue, Professor, Institute of Medical Science, The University of Tokyo.
                      Whale meat for school lunch

                      Whale meat for school lunch

                      Students are served whale meat at Wakaura Elementary School in Wakayama on July 3, 2019, under the school lunch program that began in fiscal 2017 in the western Japan prefecture hosting a well-known whaling town. Earlier in the day the students learned about the ecology of whales and whaling history in Japan from an official of the Tokyo-based Institute of Cetacean Research, who visited the school as part of its efforts to deepen people's understanding of whaling following Japan's resumption of commercial whaling on July 1. (Kyodo) ==Kyodo